What's new
Cost too high, benefit too small. No new drugs on the NHS
23 June 2025
The NHS will not be offering patients two new drugs that slow progression of Alzheimer’s Disease following a decision by the regulator, NICE. They have assessed that donanemab and lecanemab provide only a small benefit which does not justify the high cost to the health service.
Latest AI and synthetic data workshop in Birmingham
6 June 2025
DPUK’s Data Portal team is hosting the latest of a series of workshops about AI in research in collaboration with the UK Synthetic Data Community Group in Birmingham on 20th June. Registration is FREE and there is help available for the cost of travel.
Generating synthetic data using AI for neuroimaging - Webinar 29th May
28 May 2025
Seminar: Generating synthetic data using AI for neuroimaging DPUK has teamed up with the Deep Dementia Phenotyping (DEMON) Network to present a series of online webinars about applications and benefits of AI in dementia research. The first in the series was held on Thursday 29th May.
READ-OUT Study Progress: 8 UK Sites Now Open with More to Follow This Month
14 May 2025
DPUK's READ-OUT project has reached a notable milestone with eight sites now actively recruiting participants across the UK, and several more centres set to open by the end of the month. This steady expansion represents important progress in improving dementia diagnosis through blood biomarker research.
How is Dementias Platform UK enhancing research into dementia?
Watch this introductory video about Dementias Platform UK (DPUK) and how it is bringing together the best scientific minds and global leaders in the pharmaceutical industry to find new ways of detecting, treating and preventing dementia.
Get the DPUK newsletter
Sign up to subscribe to the DPUK newsletter.
Keep up to date with all that's going on at Dementias Platform UK. There are around 4 newsletters a year, which include news about developments in our infrastructure services, studies, partnerships and collaborations.
Social Media
We're currently active on LinkedIn, X (Twitter) and BlueSky where we post about every aspect of DPUK. Most of our news is shared on these channels first including jobs, new studies, programme's milestones, information on training, seminars and conferences.
Science feature
Synthetic Data: A Game-Changer for Dementia Research
DPUK is set to publish a groundbreaking report titled 'User Requirements of Synthetic Data,' exploring how synthetic data can accelerate dementia research. The report addresses critical needs identified by the research community for advancing this innovative approach. In a fascinating development, Lewis Hotchkiss from Swansea University has been sharing his pioneering work on AI and neuroimaging within trusted research environments with DPUK's Bota Godwin. Hotchkiss's research on synthetic data is creating new pathways that could transform dementia research, demonstrating how technological innovation is revolutionizing the field.
The DPUK Data Portal gives researchers rapid, secure access to multimodal datasets and millions of health research records.
Our Trials Delivery Framework matches public volunteers to the right dementia studies and has over 80 clinical sites across the UK.
DPUK's Experimental Medicine Incubator accelerates and de-risks the development of new treatments for dementia.
Work with us
Would you like to increase the international visibility of your data? Try our Data Portal.
Do you need well-characterised volunteers for your early-phase trial? Use our Trials Delivery Framework.
Is there a mechanism you would like to investigate? Explore our Experimental Medicine Incubator.